This year, theratyping, the process of matching medications with mutations, enabled more people with cystic fibrosis who have rare mutations to benefit from modulators. In the first plenary at the NACFC, we heard more about how theratyping will be used, as well as other future advances coming in CF treatment.
Site Search
Showing 41 - 44 of 44 results
Katherine Tuggle, Ph.D.
|
6 min read
Register for the 2017 North American Cystic Fibrosis Conference (NACFC) live-streamed sessions and get access to insight about many aspects of CF.
Kristin Dunn
|
3 min read
Reflecting the continued momentum we're making in the fight against cystic fibrosis, the latest Patient Registry data show steady gains in survival for people with CF. With this good news comes a lot of excitement, along with some questions.
Bruce C. Marshall, M.D.
|
4 min read
The Robert J. Beall Award, created in 2015, recognizes members of the CF scientific community whose work embodies and carries on Beall's innovative, determined and collaborative spirit in driving advances in CF research.
2 min read